Role of regulatory T cell in the pathogenesis of inflammatory bowel disease

World Journal of Gastroenterology

Volumn 22, Issue 7, 2016, Pages 2195-2205

  Yamada, Akiko ^a   Arakaki, Rieko ^a   Saito, Masako ^a   Tsunematsu, Takaaki ^a   Kudo, Yasusei ^a   Ishimaru, Naozumi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Animal model; Inflammatory bowel disease; Regulatory T cell; Therapy

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; L SELECTIN; STAT PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HOMING; CELL MIGRATION; HUMAN; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODEL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOTHERAPY; INTESTINE; METABOLISM; MUCOSAL IMMUNITY; PHENOTYPE; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNOTHERAPY; INFLAMMATION MEDIATORS; INTESTINES; PHENOTYPE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84959872333     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i7.2195     Document Type: Review

References (131)

1. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999; 11: 648-656 [PMID: 10631550 DOI: 10.1016/S0952-7915(99)00032-1]
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205 [PMID: 9649475 DOI: 10.1016/S0016-5085(98)70381-6]
3. Fiocchi C. Inflammatory bowel disease pathogenesis: therapeutic implications. Chin J Dig Dis 2005; 6: 6-9 [PMID: 15667551 DOI: 10.1111/j.1443-9573.2005.00191.x]
4. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011; 365: 1713-1725 [PMID: 22047562 DOI: 10.1056/NEJMra1102942]
5. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012; 380: 1590-1605 [PMID: 22914295 DOI: 10.1016/S0140-6736(12)60026-9]
6. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Buning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, International IBDGC, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124 [PMID: 23128233 DOI: 10.1038/nature11582]
7. Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 2013; 62: 1505-1510 [PMID: 24037875 DOI: 10.1136/gutjnl-2012-303954]
8. Huttenhower C, Kostic AD, Xavier RJ. Inflammatory bowel disease as a model for translating the microbiome. Immunity 2014; 40: 843-854 [PMID: 24950204 DOI: 10.1016/j.immuni.2014.05.013]
9. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010; 8: 564-577 [PMID: 20622892 DOI: 10.1038/nrmicro2403]
10. Neurath MF. New targets for mucosal healing and therapy in inflammatory bowel diseases. Mucosal Immunol 2014; 7: 6-19 [PMID: 24084775 DOI: 10.1038/mi.2013.73]
11. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-352 [PMID: 15785760 DOI: 10.1038/ni1178]
12. Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 1772-1788 [PMID: 23656897 DOI: 10.1097/mib.0b013e318281f5a3]
13. Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, Zeitz M, Duchmann R. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005; 128: 1868-1878 [PMID: 15940622 DOI: 10.1053/j.gastro.2005.03.043]
14. Burzyn D, Benoist C, Mathis D. Regulatory T cells in nonlymphoid tissues. Nat Immunol 2013; 14: 1007-1013 [PMID: 24048122 DOI: 10.1038/ni.2683]
15. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011; 140: 957-965 [PMID: 21147109 DOI: 10.1053/j.gastro.2010.12.002]
16. Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 2012; 105: 263-320 [PMID: 22137435 DOI: 10.1016/B978-0-12-394596-9.00009-3]
17. Martin B, Banz A, Bienvenu B, Cordier C, Dautigny N, Bécourt C, Lucas B. Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo. J Immunol 2004; 172: 3391-3398 [PMID: 15004137 DOI: 10.4049/jimmunol.172.6.3391]
18. Niederau C, Backmerhoff F, Schumacher B, Niederau C. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Hepatogastroenterology 1997; 44: 90-107 [PMID: 9058126]
19. Nielsen OH, Ciardelli T, Wu Z, Langholz E, Kirman I. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. Am J Gastroenterol 1995; 90: 1301-1306 [PMID: 7639234]
20. Colombo BM, Scalvenzi T, Benlamara S, Pollet N. Microbiota and mucosal immunity in amphibians. Front Immunol 2015; 6: 111 [PMID: 25821449 DOI: 10.3389/fimmu.2015.00111]
21. McAvoy JW, Dixon KE. Cell specialization in the small intestinal epithelium of adult Xenopus laevis: structural aspects. J Anat 1978; 125: 155-169 [PMID: 632211]
22. Krishnan K, Arnone B, Buchman A. Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing. Inflamm Bowel Dis 2011; 17: 410-422 [PMID: 20848489 DOI: 10.1002/ibd.21316]
23. Paclik D, Lohse K, Wiedenmann B, Dignass AU, Sturm A. Galectin-2 and-4, but not galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. Inflamm Bowel Dis 2008; 14: 1366-1372 [PMID: 18484670 DOI: 10.1002/ibd.20499]
24. Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol 2008; 14: 348-353 [PMID: 18200658 DOI: 10.3748/wjg.14.348]
25. Lassen KG, Kuballa P, Conway KL, Patel KK, Becker CE, Peloquin JM, Villablanca EJ, Norman JM, Liu TC, Heath RJ, Becker ML, Fagbami L, Horn H, Mercer J, Yilmaz OH, Jaffe JD, Shamji AF, Bhan AK, Carr SA, Daly MJ, Virgin HW, Schreiber SL, Stappenbeck TS, Xavier RJ. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proc Natl Acad Sci USA 2014; 111: 7741-7746 [PMID: 24821797 DOI: 10.1073/pnas.1407001111]
26. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-317 [PMID: 21677747 DOI: 10.1038/nature10209]
27. Rubino SJ, Selvanantham T, Girardin SE, Philpott DJ. Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol 2012; 24: 398-404 [PMID: 22677577 DOI: 10.1016/j.coi.2012.04.010]
28. Barreau F, Meinzer U, Chareyre F, Berrebi D, Niwa-Kawakita M, Dussaillant M, Foligne B, Ollendorff V, Heyman M, Bonacorsi S, Lesuffleur T, Sterkers G, Giovannini M, Hugot JP. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS One 2007; 2: e523 [PMID: 17565376 DOI: 10.1371/journal.pone.0000523]
29. Watanabe T, Asano N, Murray PJ, Ozato K, Tailor P, Fuss IJ, Kitani A, Strober W. Muramyl dipeptide activation of nucleotidebinDing oligomerization domain 2 protects mice from experimental colitis. J Clin Invest 2008; 118: 545-559 [PMID: 18188453]
30. Macho Fernandez E, Valenti V, Rockel C, Hermann C, Pot B, Boneca IG, Grangette C. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 2011; 60: 1050-1059 [PMID: 21471573 DOI: 10.1136/gut.2010.232918]
31. Venturi GM, Conway RM, Steeber DA, Tedder TF. CD25+CD4+ regulatory T cell migration requires L-selectin expression: L-selectin transcriptional regulation balances constitutive receptor turnover. J Immunol 2007; 178: 291-300 [PMID: 17182566 DOI: 10.4049/jimmunol.178.1.291]
32. Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med 2007; 204: 735-745 [PMID: 17371928 DOI: 10.1084/jem.20061405]
33. Suffia I, Reckling SK, Salay G, Belkaid Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 2005; 174: 5444-5455 [PMID: 15845457 DOI: 10.4049/jimmunol.174.9.5444]
34. Denning TL, Kim G, Kronenberg M. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J Immunol 2005; 174: 7487-7491 [PMID: 15944246 DOI: 10.4049/jimmunol.174.12.7487]
35. Yuan Q, Bromley SK, Means TK, Jones KJ, Hayashi F, Bhan AK, Luster AD. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J Exp Med 2007; 204: 1327-1334 [PMID: 17548518 DOI: 10.1084/jem.20062076]
36. Kang SG, Piniecki RJ, Hogenesch H, Lim HW, Wiebke E, Braun SE, Matsumoto S, Kim CH. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine. Gastroenterology 2007; 132: 966-981 [PMID: 17324406 DOI: 10.1053/j.gastro.2007.01.008]
37. Guo Z, Jang MH, Otani K, Bai Z, Umemoto E, Matsumoto M, Nishiyama M, Yamasaki M, Ueha S, Matsushima K, Hirata T, Miyasaka M. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Int Immunol 2008; 20: 307-315 [PMID: 18184698 DOI: 10.1093/intimm/dxm143]
38. Corridoni D, Arseneau KO, Cominelli F. Inflammatory bowel disease. Immunol Lett 2014; 161: 231-235 [PMID: 24938525 DOI: 10.1016/j.imlet.2014.04.004]
39. Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci 2006; 1072: 28-38 [PMID: 17057188 DOI: 10.1196/annals.1326.008]
40. Uhlig HH, Powrie F. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease. Eur J Immunol 2009; 39: 2021-2026 [PMID: 19672896 DOI: 10.1002/eji.200939602]
41. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005; 206: 260-276 [PMID: 16048554 DOI: 10.1111/j.0105-2896.2005.00291.x]
42. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2: 204 [PMID: 18030708 DOI: 10.1016/j.chom.2007.08.002]
43. Boehm F, Martin M, Kesselring R, Schiechl G, Geissler EK, Schlitt HJ, Fichtner-Feigl S. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. BMC Gastroenterol 2012; 12: 97 [PMID: 22849659 DOI: 10.1186/1471-230X-12-97]
44. Reardon C, Wang A, McKay DM. Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death. J Immunol 2008; 180: 8316-8326 [PMID: 18523298 DOI: 10.4049/jimmunol.180.12.8316]
45. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188: 1929-1939 [PMID: 9815270 DOI: 10.1084/jem.188.10.1929]
46. Singh VP, Patil CS, Jain NK, Singh A, Kulkarni SK. Effect of nimesulide on acetic acid-and leukotriene-induced inflammatory bowel disease in rats. Prostaglandins Other Lipid Mediat 2003; 71: 163-175 [PMID: 14518559 DOI: 10.1016/S1098-8823(03)00038-8]
47. Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997; 65: 3126-3131 [PMID: 9234764]
48. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009; 31: 401-411 [PMID: 19766083 DOI: 10.1016/j.immuni.2009.08.011]
49. Ostman S, Rask C, Wold AE, Hultkrantz S, Telemo E. Impaired regulatory T cell function in germ-free mice. Eur J Immunol 2006; 36: 2336-2346 [PMID: 16897813 DOI: 10.1002/eji.200535244]
50. Singh B, Read S, Asseman C, Malmström V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182: 190-200 [PMID: 11722634 DOI: 10.1034/j.1600-065X.2001.1820115.x]
51. Strauch UG, Obermeier F, Grunwald N, Gürster S, Dunger N, Schultz M, Griese DP, Mähler M, Schölmerich J, Rath HC. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 2005; 54: 1546-1552 [PMID: 15987795 DOI: 10.1136/gut.2004.059451]
52. Tanoue T, Honda K. Induction of Treg cells in the mouse colonic mucosa: a central mechanism to maintain host-microbiota homeostasis. Semin Immunol 2012; 24: 50-57 [PMID: 22172550 DOI: 10.1016/j.smim.2011.11.009]
53. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008; 4: 337-349 [PMID: 18854238 DOI: 10.1016/j.chom.2008.09.009]
54. Spahn TW, Ross M, von Eiff C, Maaser C, Spieker T, Kannengiesser K, Domschke W, Kucharzik T. CD4+ T cells transfer resistance against Citrobacter rodentium-induced infectious colitis by induction of Th 1 immunity. Scand J Immunol 2008; 67: 238-244 [PMID: 18261038 DOI: 10.1111/j.1365-3083.2007.02063. x]
55. Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, Zhu Q, Grigg ME, Berzofsky JA, Belkaid Y. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008; 29: 637-649 [PMID: 18835196 DOI: 10.1016/j.immuni.2008.08.009]
56. Poussier P, Ning T, Chen J, Banerjee D, Julius M. Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis. Gastroenterology 2000; 118: 880-891 [PMID: 10784587 DOI: 10.1016/S0016-5085(00)70174-0]
57. Sohn KJ, Shah SA, Reid S, Choi M, Carrier J, Comiskey M, Terhorst C, Kim YI. Molecular genetics of ulcerative colitisassociated colon cancer in the interleukin 2-and beta(2)-microglobulin-deficient mouse. Cancer Res 2001; 61: 6912-6917 [PMID: 11559569]
58. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM. T helper cell 1-type CD4 T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 1996; 184: 241-251 [DOI: 10.1084/jem.184.1.241]
59. Waidmann M, Bechtold O, Frick JS, Lehr HA, Schubert S, Dobrindt U, Loeffler J, Bohn E, Autenrieth IB. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 2003; 125: 162-177 [PMID: 12851881 DOI: 10.1016/S0016-5085(03)00672-3]
60. Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L. Helicobacter-induced inflammatory bowel disease in IL-10-and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 2001; 281: G764-G778 [PMID: 11518689]
61. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y, Fuss IJ, Strober W. Nucleotide binDing oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006; 25: 473-485 [PMID: 16949315 DOI: 10.1016/j.immuni.2006.06.018]
62. Fox JG, Rogers AB, Whary MT, Ge Z, Taylor NS, Xu S, Horwitz BH, Erdman SE. Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distenDing toxin despite persistent colonization with both strains. Infect Immun 2004; 72: 1116-1125 [DOI: 10.1128/IAI.72.2.1116-1125.2004]
63. Dennis A, Kudo T, Kruidenier L, Girard F, Crepin VF, MacDonald TT, Frankel G, Wiles S. The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium. Infect Immun 2008; 76: 4978-4988 [PMID: 18694964 DOI: 10.1128/IAI.00736-08]
64. Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C, Vallance BA. MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol 2008; 10: 618-631 [PMID: 17979981 DOI: 10.1111/j.1462-5822.2007.01071.x]
65. Hapfelmeier S, Stecher B, Barthel M, Kremer M, Müller AJ, Heikenwalder M, Stallmach T, Hensel M, Pfeffer K, Akira S, Hardt WD. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol 2005; 174: 1675-1685 [PMID: 15661931 DOI: 10.4049/jimmunol.174.3.1675]
66. Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol 2002; 160: 739-751 [PMID: 11839595 DOI: 10.1016/S0002-9440(10)64894-8]
67. Beckwith J, Cong Y, Sundberg JP, Elson CO, Leiter EH. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology 2005; 129: 1473-1484 [PMID: 16285949 DOI: 10.1053/j.gastro.2005.07.057]
68. Tanner SM, Staley EM, Lorenz RG. Altered generation of induced regulatory T cells in the FVB.mdr1a-/-mouse model of colitis. Mucosal Immunol 2013; 6: 309-323 [PMID: 22874899 DOI: 10.1038/mi.2012.73]
69. Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL. Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/-mice results in colitis that progresses to dysplasia. Am J Pathol 2005; 166: 1793-1806 [PMID: 15920164 DOI: 10.1016/S0002-9440(10)62489-3]
70. Uematsu S, Jang MH, Chevrier N, Guo Z, Kumagai Y, Yamamoto M, Kato H, Sougawa N, Matsui H, Kuwata H, Hemmi H, Coban C, Kawai T, Ishii KJ, Takeuchi O, Miyasaka M, Takeda K, Akira S. Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat Immunol 2006; 7: 868-874 [PMID: 16829963 DOI: 10.1038/ni1362]
71. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999; 10: 387-398 [PMID: 10204494 DOI: 10.1016/S1074-7613(00)80038-2]
72. Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR, Bhan A, Autschbach F, Sullivan BM, Szabo SJ, Glimcher LH, Blumberg RS. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002; 195: 1129-1143 [DOI: 10.1084/jem.20011956]
73. Murata Y, Yamashita A, Saito T, Sugamura K, Hamuro J. The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice. Int Immunol 2002; 14: 627-636 [PMID: 12039914 DOI: 10.1093/intimm/dxf031]
74. Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow CC, McGuckin MA. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 2008; 5: e54 [PMID: 18318598 DOI: 10.1371/journal.pmed.0050054]
75. Hammer GE, Turer EE, Taylor KE, Fang CJ, Advincula R, Oshima S, Barrera J, Huang EJ, Hou B, Malynn BA, Reizis B, DeFranco A, Criswell LA, Nakamura MC, Ma A. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 2011; 12: 1184-1193 [PMID: 22019834 DOI: 10.1038/ni.2135]
76. Chinen T, Kobayashi T, Ogata H, Takaesu G, Takaki H, Hashimoto M, Yagita H, Nawata H, Yoshimura A. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved. Gastroenterology 2006; 130: 373-388 [PMID: 16472593 DOI: 10.1053/j.gastro.2005.10.051]
77. Sledzi?ska A, Hemmers S, Mair F, Gorka O, Ruland J, Fairbairn L, Nissler A, Müller W, Waisman A, Becher B, Buch T. TGF- signalling is required for CD4+ T cell homeostasis but dispensable for regulatory T cell function. PLoS Biol 2013; 11: e1001674 [PMID: 24115907 DOI: 10.1371/journal.pbio.1001674]
78. Park SG, Mathur R, Long M, Hosh N, Hao L, Hayden MS, Ghosh S. T regulatory cells maintain intestinal homeostasis by suppressing T cells. Immunity 2010; 33: 791-803 [PMID: 21074460 DOI: 10.1016/j.immuni.2010.10.014]
79. Salehi S, Bankoti R, Benevides L, Willen J, Couse M, Silva JS, Dhall D, Meffre E, Targan S, Martins GA. B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4+ T cells. J Immunol 2012; 189: 5682-5693 [PMID: 23162130 DOI: 10.4049/jimmunol.1201966]
80. O'Malley JT, Eri RD, Stritesky GL, Mathur AN, Chang HC, Hogenesch H, Srinivasan M, Kaplan MH. STAT4 isoforms differentially regulate Th1 cytokine production and the severity of inflammatory bowel disease. J Immunol 2008; 181: 5062-5070 [PMID: 18802110 DOI: 10.4049/jimmunol.181.7.5062]
81. Clegg CH, Rulffes JT, Haugen HS, Hoggatt IH, Aruffo A, Durham SK, Farr AG, Hollenbaugh D. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. Int Immunol 1997; 9: 1111-1122 [PMID: 9263008 DOI: 10.1093/intimm/9.8.1111]
82. Kawamura T, Kanai T, Dohi T, Uraushihara K, Totsuka T, Iiyama R, Taneda C, Yamazaki M, Nakamura T, Higuchi T, Aiba Y, Tsubata T, Watanabe M. Ectopic CD40 ligand expression on B cells triggers intestinal inflammation. J Immunol 2004; 172: 6388-6397 [PMID: 15128830 DOI: 10.4049/jimmunol.172.10.6388]
83. Ishikawa D, Okazawa A, Corridoni D, Jia LG, Wang XM, Guanzon M, Xin W, Arseneau KO, Pizarro TT, Cominelli F. Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn' s disease. Mucosal Immunol 2013; 6: 267-275 [PMID: 22785225 DOI: 10.1038/mi.2012.67]
84. Elson CO, Cong Y, Sundberg J. The C3H/HeJBir mouse model: a high susceptibility phenotype for colitis. Int Rev Immunol 2000; 19: 63-75 [PMID: 10723678 DOI: 10.3109/08830180009048390]
85. Johnson LD, Ausman LM, Rolland RM, Chalifoux LV, Russell RG. Campylobacter-induced enteritis and diarrhea in captive cotton-top tamarins (Saguinus oedipus) during the first year of life. Comp Med 2001; 51: 257-261 [PMID: 11924782]
86. Ishimaru N, Yamada A, Kohashi M, Arakaki R, Takahashi T, Izumi K, Hayashi Y. Development of inflammatory bowel disease in Long-Evans Cinnamon rats based on CD4+CD25+Foxp3+ regulatory T cell dysfunction. J Immunol 2008; 180: 6997-7008 [PMID: 18453622 DOI: 10.4049/jimmunol.180.10.6997]
87. Agui T, Oka M, Yamada T, Sakai T, Izumi K, Ishida Y, Himeno K, Matsumoto K. Maturational arrest from CD4+8+ to CD4+8-thymocytes in a mutant strain (LEC) of rat. J Exp Med 1990; 172: 1615-1624 [PMID: 2147947 DOI: 10.1084/jem.172.6.1615]
88. Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011; 11: 119-130 [PMID: 21267013 DOI: 10.1038/nri2916]
89. Liston A, Gray DH. Homeostatic control of regulatory T cell diversity. Nat Rev Immunol 2014; 14: 154-165 [PMID: 24481337 DOI: 10.1038/nri3605]
90. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330-336 [PMID: 12612578 DOI: 10.1038/ni904]
91. Feuerer M, Hill JA, Kretschmer K, von Boehmer H, Mathis D, Benoist C. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci USA 2010; 107: 5919-5924 [PMID: 20231436 DOI: 10.1073/pnas.1002006107]
92. Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, Ziegelbauer J, Yassai M, Li SH, Relland LM, Wise PM, Chen A, Zheng YQ, Simpson PM, Gorski J, Salzman NH, Hessner MJ, Chatila TA, Williams CB. A requisite role for induced regulatory T cells in tolerance based on expanDing antigen receptor diversity. Immunity 2011; 35: 109-122 [PMID: 21723159 DOI: 10.1016/j.immuni.2011.03.029]
93. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009; 30: 616-625 [PMID: 19464984 DOI: 10.1016/j.immuni.2009.04.009]
94. Relland LM, Williams JB, Relland GN, Haribhai D, Ziegelbauer J, Yassai M, Gorski J, Williams CB. The TCR repertoires of regulatory and conventional T cells specific for the same foreign antigen are distinct. J Immunol 2012; 189: 3566-3574 [PMID: 22933635 DOI: 10.4049/jimmunol.1102646]
95. Almeida AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002; 169: 4850-4860 [PMID: 12391195 DOI: 10.4049/jimmunol.169.9.4850]
96. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17: 167-178 [PMID: 12196288 DOI: 10.1016/S1074-7613(02)00367-9]
97. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Pénit C. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10: 371-378 [PMID: 9620592 DOI: 10.1093/intimm/10.4.371]
98. Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005; 201: 723-735 [PMID: 15753206 DOI: 10.1084/jem.20041982]
99. Lee JH, Kang SG, Kim CH. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J Immunol 2007; 178: 301-311 [PMID: 17182567 DOI: 10.4049/jimmunol.178.1.301]
100. Kleinewietfeld M, Puentes F, Borsellino G, Battistini L, Rötzschke O, Falk K. CCR6 expression defines regulatory effector/memorylike cells within the CD25(+)CD4+ T-cell subset. Blood 2005; 105: 2877-2886 [PMID: 15613550 DOI: 10.1182/blood-2004-07-2505]
101. Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, Debes GF, Lauber J, Frey O, Przybylski GK, Niesner U, de la Rosa M, Schmidt CA, Bräuer R, Buer J, Scheffold A, Hamann A. Developmental stage, phenotype, and migration distinguish naive-and effector/memory-like CD4+ regulatory T cells. J Exp Med 2004; 199: 303-313 [PMID: 14757740 DOI: 10.1084/jem.20031562]
102. Stephens GL, Andersson J, Shevach EM. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J Immunol 2007; 178: 6901-6911 [PMID: 17513739 DOI: 10.4049/jimmunol.178.11.6901]
103. Sather BD, Treuting P, Perdue N, Miazgowicz M, Fontenot JD, Rudensky AY, Campbell DJ. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 2007; 204: 1335-1347 [PMID: 17548521 DOI: 10.1084/jem.20070081]
104. Ishimaru N, Nitta T, Arakaki R, Yamada A, Lipp M, Takahama Y, Hayashi Y. In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy. PLoS One 2010; 5: e8588 [PMID: 20052419 DOI: 10.1371/journal.pone.0008588]
105. Ishimaru N, Yamada A, Nitta T, Arakaki R, Lipp M, Takahama Y, Hayashi Y. CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy. Am J Pathol 2012; 180: 199-208 [PMID: 22067914 DOI: 10.1016/j.ajpath.2011.09.027]
106. Bilate AB, Lafaille JJ. It takes two to tango. Immunity 2011; 35: 6-8 [PMID: 21777793 DOI: 10.1016/j.immuni.2011.07.003]
107. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886 [PMID: 14676299 DOI: 10.1084/jem.20030152]
108. Atarashi K, Umesaki Y, Honda K. Microbiotal influence on T cell subset development. Semin Immunol 2011; 23: 146-153 [PMID: 21292500 DOI: 10.1016/j.smim.2011.01.010]
109. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207-214 [PMID: 11722636 DOI: 10.1034/j.1600-065X.2001.1820117.x]
110. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011; 241: 241-259 [PMID: 21488901 DOI: 10.1111/j.1600-065X.2011.01017.x]
111. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337-341 [PMID: 21205640 DOI: 10.1126/science.1198469]
112. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569-573 [PMID: 23828891 DOI: 10.1126/science.1241165]
113. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930-939 [PMID: 19633656 DOI: 10.1038/nm.2002]
114. Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D. PPAR- is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012; 486: 549-553 [PMID: 22722857]
115. Kullberg MC, Hay V, Cheever AW, Mamura M, Sher A, Letterio JJ, Shevach EM, Piccirillo CA. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005; 35: 2886-2895 [PMID: 16180248 DOI: 10.1002/eji.200526106]
116. Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 2010; 30: 80-89 [PMID: 19936899 DOI: 10.1007/s10875-009-9345-1]
117. Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000; 21: 479-483 [PMID: 11071525 DOI: 10.1016/S0167-5699(00)01712-6]
118. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89: 587-596 [PMID: 9160750 DOI: 10.1016/S0092-8674(00)80240-8]
119. Asnagli H, Murphy KM. Stability and commitment in T helper cell development. Curr Opin Immunol 2001; 13: 242-247 [PMID: 11228419 DOI: 10.1016/S0952-7915(00)00210-7]
120. Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997; 159: 6276-6282 [PMID: 9550432]
121. Iijima H, Neurath MF, Nagaishi T, Glickman JN, Nieuwenhuis EE, Nakajima A, Chen D, Fuss IJ, Utku N, Lewicki DN, Becker C, Gallagher TM, Holmes KV, Blumberg RS. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J Exp Med 2004; 199: 471-482 [PMID: 14970176 DOI: 10.1084/jem.20030437]
122. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFNgamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157: 1261-1270 [PMID: 8757634]
123. Ueno A, Jijon H, Chan R, Ford K, Hirota C, Kaplan GG, Beck PL, Iacucci M, Fort Gasia M, Barkema HW, Panaccione R, Ghosh S. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19: 2522-2534 [PMID: 24097227 DOI: 10.1097/MIB.0b013e3182a85709]
124. Harrison OJ, Srinivasan N, Pott J, Schiering C, Krausgruber T, Ilott NE, Maloy KJ. Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine. Mucosal Immunol 2015; 8: 1226-1236 [PMID: 25736457 DOI: 10.1038/mi.2015.13]
125. McNamee EN, Masterson JC, Veny M, Collins CB, Jedlicka P, Byrne FR, Ng GY, Rivera-Nieves J. Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn' s-like murine ileitis. J Leukoc Biol 2015; 97: 1011-1022 [PMID: 25637591 DOI: 10.1189/jlb.3HI0614-303R]
126. Globig AM, Hennecke N, Martin B, Seidl M, Ruf G, Hasselblatt P, Thimme R, Bengsch B. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-?+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease. Inflamm Bowel Dis 2014; 20: 2321-2329 [PMID: 25248005 DOI: 10.1097/MIB.0000000000000210]
127. Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quévrain E, Bridonneau C, Preisser L, Asehnoune K, Labarrière N, Altare F, Sokol H, Jotereau F. CD4CD8 lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease. PLoS Biol 2014; 12: e1001833 [PMID: 24714093 DOI: 10.1371/journal. pbio.1001833]
128. Boschetti G, Nancey S, Sardi F, Roblin X, Flourié B, Kaiserlian D. Therapy with anti-TNF? antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17: 160-170 [PMID: 20848510 DOI: 10.1002/ibd.21308]
129. Li Z, Arijs I, De Hertogh G, Vermeire S, Noman M, Bullens D, Coorevits L, Sagaert X, Schuit F, Rutgeerts P, Ceuppens JL, Van Assche G. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responDing to infliximab. Inflamm Bowel Dis 2010; 16: 1299-1310 [PMID: 20196149 DOI: 10.1002/ibd.21229]
130. Veltkamp C, Anstaett M, Wahl K, Möller S, Gangl S, Bachmann O, Hardtke-Wolenski M, Länger F, Stremmel W, Manns MP, Schulze-Osthoff K, Bantel H. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNF? treatment. Gut 2011; 60: 1345-1353 [PMID: 21459928 DOI: 10.1136/gut.2010.217117]
131. Canavan JB, Scottà C, Vossenkämper A, Goldberg R, Elder MJ, Shoval I, Marks E, Stolarczyk E, Lo JW, Powell N, Fazekasova H, Irving PM, Sanderson JD, Howard JK, Yagel S, Afzali B, MacDonald TT, Hernandez-Fuentes MP, Shpigel NY, Lombardi G, Lord GM. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease. Gut 2015; Epub ahead of print [PMID: 25715355 DOI: 10.1136/gutjnl-2014-306919]